EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients

EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients

Item
http://www.wikidata.org/entity/Q28294581
Biomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRASEGFR gene copy number as a prognostic marker in colorectal cancer patients treated with cetuximab or panitumumab: a systematic review and meta analysisHER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients.EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment: a meta-analysis.Serum HER 2 extracellular domain level is correlated with tissue HER 2 status in metastatic gastric or gastro-oesophageal junction adenocarcinomaClinicopathologic characteristics and therapeutic responses of Chinese patients with non-small cell lung cancer who harbor an anaplastic lymphoma kinase rearrangement.Molecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma.High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR.ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.Individualized therapy for metastatic colorectal cancer.Molecular cytogenetics: recent developments and applications in cancer.Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study.The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma.Clinical and prognostic value of MET gene copy number gain and chromosome 7 polysomy in primary colorectal cancer patients.Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer.
P2860

EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients

Item
http://www.wikidata.org/entity/Q28294581
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
EGFR fluorescence in situ hybr ...... tic colorectal cancer patients
@ast
EGFR fluorescence in situ hybr ...... tic colorectal cancer patients
@en
EGFR fluorescence in situ hybr ...... tic colorectal cancer patients
@nl
type
label
EGFR fluorescence in situ hybr ...... tic colorectal cancer patients
@ast
EGFR fluorescence in situ hybr ...... tic colorectal cancer patients
@en
EGFR fluorescence in situ hybr ...... tic colorectal cancer patients
@nl
prefLabel
EGFR fluorescence in situ hybr ...... tic colorectal cancer patients
@ast
EGFR fluorescence in situ hybr ...... tic colorectal cancer patients
@en
EGFR fluorescence in situ hybr ...... tic colorectal cancer patients
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
EGFR fluorescence in situ hybr ...... tic colorectal cancer patients
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-10-0208
P407
P433
P478
P50
P577
P698
P921